Tapewire

Nasdaq · USD

ASTH

Astrana Health, Inc.

Export transactions ↓
Tapewire entity
4538
SEC CIK
0001083446
Parsed reports
385

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
December 15, 2023 Filed Dec 18, 2023 21:39 UTC GrantCommon Stock 5,750 $0.00 $0.00
Disclosure

SEC source: 0001104659-23-126910 · tm2333076-8_4seq1.xml · nonDerivative · entry 1

Schmidt David · CIK 0001594029 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,750

F1 · shares: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan, which shall vest on December 9, 2024 (or if earlier, upon the date of the Reporting Person's cessation of service on the Issuer's board of directors).

F2 · balance_after: Includes 5,750 shares of restricted stock, which will vest on December 9, 2024.

Read SEC document
December 15, 2023 Filed Dec 19, 2023 00:54 UTC
Dai, WeiliDirector
GrantCommon Stock 3,650 $0.00 $0.00
Disclosure

SEC source: 0001104659-23-127015 · tm2333076-2_4seq1.xml · nonDerivative · entry 1

Dai, Weili · CIK 0001134140 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,650

F1 · shares: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan, which shall vest on December 9, 2024 (or if earlier, upon the date of the Reporting Person's cessation of service on the Issuer's board of directors).

F2 · balance_after: Includes 3,650 shares of restricted stock, which will vest on December 9, 2024.

Read SEC document
December 15, 2023 Filed Dec 18, 2023 21:38 UTC GrantCommon Stock 4,750 $0.00 $0.00
Disclosure

SEC source: 0001104659-23-126906 · tm2333076-7_4seq1.xml · nonDerivative · entry 1

Mazdyasni Matthew · CIK 0001809915 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,750

F1 · shares: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan, which shall vest on December 9, 2024 (or if earlier, upon the date of the Reporting Person's cessation of service on the Issuer's board of directors).

F2 · balance_after: Includes 4,750 shares of restricted stock, which will vest on December 9, 2024.

Read SEC document
December 15, 2023 Filed Dec 18, 2023 21:36 UTC
Dong LindaDirector
GrantCommon Stock 3,650 $0.00 $0.00
Disclosure

SEC source: 0001104659-23-126904 · tm2333076-6_4seq1.xml · nonDerivative · entry 1

Marsh Linda · CIK 0001765204 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,150

F1 · shares: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan, which shall vest on December 9, 2024 (or if earlier, upon the date of the Reporting Person's cessation of service on the Issuer's board of directors).

F2 · balance_after: Includes 3,650 shares of restricted stock, which will vest on December 9, 2024.

Read SEC document
December 15, 2023 Filed Dec 18, 2023 21:35 UTC
Lam Thomas S.Director · President and Co-CEO
GrantCommon Stock 30,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-23-126900 · tm2333076-5_4seq1.xml · nonDerivative · entry 3

Lam Thomas S. · CIK 0001664499 · Director · President and Co-CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 381,855

F4 · shares: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, and subject to the achievement of a pre-established performance goal, the shares of restricted stock shall, based on the date the performance goal is achieved, vest either (i) in four equal annual installments, beginning on a date during the first quarter of 2025 to be determined by the compensation committee of the Issuer's board of directors or (ii) three annual installments of 15,000, 7,500 and 7,500, respectively, beginning on a date during the first quarter of 2026 to be determined by the compensation committee.

F5 · balance_after: Includes 111,748 shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 21,748 shares, which will vest on November 2, 2024; (ii) 30,000 shares, which will vest in four equal annual installments beginning in the first quarter of 2025; (iii) 30,000 shares, which will vest upon achievement of certain pre-established performance goals; and (iv) 30,000 shares, which will vest upon achievement of certain pre-established performance goals.

Read SEC document
December 15, 2023 Filed Dec 18, 2023 21:35 UTC
Lam Thomas S.Director · President and Co-CEO
GrantCommon Stock 30,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-23-126900 · tm2333076-5_4seq1.xml · nonDerivative · entry 2

Lam Thomas S. · CIK 0001664499 · Director · President and Co-CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 351,855

F3 · shares: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, and subject to the achievement of a pre-established performance goal, the shares of restricted stock shall vest in four equal annual installments, beginning on a date during the first quarter of 2025 to be determined by the compensation committee of the Issuer's board of directors.

Read SEC document
December 15, 2023 Filed Dec 18, 2023 21:35 UTC
Lam Thomas S.Director · President and Co-CEO
GrantCommon Stock 30,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-23-126900 · tm2333076-5_4seq1.xml · nonDerivative · entry 1

Lam Thomas S. · CIK 0001664499 · Director · President and Co-CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 321,855

F2 · shares: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, the shares of restricted stock shall vest in four equal annual installments beginning on a date during the first quarter of 2025 to be determined by the compensation committee of the Issuer's board of directors.

Read SEC document
December 15, 2023 Filed Dec 18, 2023 21:33 UTC GrantCommon Stock 6,750 $0.00 $0.00
Disclosure

SEC source: 0001104659-23-126898 · tm2333076-4_4seq1.xml · nonDerivative · entry 1

Kitayama Mitchell W · CIK 0001333154 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,750

F1 · shares: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan, which shall vest on December 9, 2024 (or if earlier, upon the date of the Reporting Person's cessation of service on the Issuer's board of directors).

F2 · balance_after: Includes 6,750 shares of restricted stock, which will vest on December 9, 2024.

Read SEC document
December 15, 2023 Filed Dec 18, 2023 21:31 UTC
Chiang JohnDirector
GrantCommon Stock 4,750 $0.00 $0.00
Disclosure

SEC source: 0001104659-23-126896 · tm2333076-1_4seq1.xml · nonDerivative · entry 1

Chiang John · CIK 0001765302 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,850

F1 · shares: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan, which shall vest on December 9, 2024 (or if earlier, upon the date of the Reporting Person's cessation of service on the Issuer's board of directors).

F2 · balance_after: Includes 4,750 shares of restricted stock, which will vest on December 9, 2024.

Read SEC document
December 15, 2023 Filed Dec 18, 2023 21:33 UTC
Sim Kenneth T.Director · Executive Chairman
GrantCommon Stock 30,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-23-126897 · tm2333076-3_4seq1.xml · nonDerivative · entry 3

Sim Kenneth T. · CIK 0001725499 · Director · Executive Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 381,859

F7 · shares: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, and subject to the achievement of a pre-established performance goal, the shares of restricted stock shall, based on the date the performance goal is achieved, vest either (i) in four equal annual installments, beginning on a date during the first quarter of 2025 to be determined by the compensation committee of the Issuer's board of directors or (ii) three annual installments of 15,000, 7,500 and 7,500, respectively, beginning on a date during the first quarter of 2026 to be determined by the compensation committee.

F8 · balance_after: Includes 111,748 shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 21,748 shares, which vest on November 2, 2024; (ii) 30,000 shares, which vest in four equal annual installments beginning in the first quarter of 2025; (iii) 30,000 shares, which will vest upon achievement of certain pre-established performance goals; and (iv) 30,000 shares, which will vest upon achievement of certain pre-established performance goals.

Read SEC document
December 15, 2023 Filed Dec 18, 2023 21:33 UTC
Sim Kenneth T.Director · Executive Chairman
GrantCommon Stock 30,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-23-126897 · tm2333076-3_4seq1.xml · nonDerivative · entry 2

Sim Kenneth T. · CIK 0001725499 · Director · Executive Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 351,859

F6 · shares: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, and subject to the achievement of a pre-established performance goal, the shares of restricted stock shall vest in four equal annual installments, beginning on a date during the first quarter of 2025 to be determined by the compensation committee of the Issuer's board of directors.

Read SEC document
December 15, 2023 Filed Dec 18, 2023 21:33 UTC
Sim Kenneth T.Director · Executive Chairman
GrantCommon Stock 30,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-23-126897 · tm2333076-3_4seq1.xml · nonDerivative · entry 1

Sim Kenneth T. · CIK 0001725499 · Director · Executive Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 321,859

F5 · shares: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, the shares of restricted stock shall vest in four equal annual installments beginning on a date during the first quarter of 2025 to be determined by the compensation committee of the Issuer's board of directors.

Read SEC document
December 15, 2023 Filed Dec 20, 2023 02:10 UTC
Vong JohnChief Accounting Officer
GrantCommon Stock 7,100 $0.00 $0.00
Disclosure

SEC source: 0001104659-23-127452 · tm2333076-9_4seq1.xml · nonDerivative · entry 5

Vong John · CIK 0001572846 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,253

F5 · shares: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, 887 shares of restricted stock will vest on December 31, 2023, and the remaining 6,213 shares of restricted stock shall vest in seven substantially equal semi-annual installments beginning on May 12, 2024.

F6 · balance_after: Includes 18,511 shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 2,829 shares, of which 942 shares will vest on each of July 11, 2024 and July 11, 2025 and 945 shares will vest on July 11, 2026; (ii) 570 shares, which will vest in three equal annual installments beginning on November 30, 2024; (iii) 760 shares, which will vest upon achievement of certain pre-established performance goals; (iv) 1,813 shares, of which 226 shares will vest on December 31, 2023 and the remaining shares will vest in seven equal semi-annual installments beginning on May 12, 2024, subject to the achievement of certain pre-established performance goals; (v) 1,813 shares, of which 226 shares will vest on December 31, 2023 and the remaining shares will vest in seven equal semi-annual installments beginning on May 12, 2024, subject to the achievement of certain pre-established performance goals;

F7 · balance_after: (cont.) (vi) 1,813 shares, of which 226 shares will vest on December 31, 2023 and the remaining shares will vest in seven equal semi-annual installments beginning on May 12, 2024, subject to the achievement of certain pre-established performance goals; (vii) 1,813 shares, of which 226 shares will vest on December 31, 2023 and the remaining shares will vest in seven equal semi-annual installments beginning on May 12, 2024, subject to the achievement of certain pre-established performance goals; and (viii) 7,100 shares, of which 887 shares will vest on December 31, 2023, and the remaining shares will vest in seven equal semi-annual installments beginning on May 12, 2024.

Read SEC document
December 15, 2023 Filed Dec 20, 2023 02:10 UTC
Vong JohnChief Accounting Officer
GrantCommon Stock 1,813 $0.00 $0.00
Disclosure

SEC source: 0001104659-23-127452 · tm2333076-9_4seq1.xml · nonDerivative · entry 4

Vong John · CIK 0001572846 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,153

F4 · shares: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, and subject to the achievement of applicable pre-established performance goals, 226 shares of restricted stock will vest on December 31, 2023, and the remaining 1,587 shares of restricted stock shall vest in seven substantially equal semi-annual installments beginning on May 12, 2024.

Read SEC document
December 15, 2023 Filed Dec 20, 2023 02:10 UTC
Vong JohnChief Accounting Officer
GrantCommon Stock 1,813 $0.00 $0.00
Disclosure

SEC source: 0001104659-23-127452 · tm2333076-9_4seq1.xml · nonDerivative · entry 3

Vong John · CIK 0001572846 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,340

F3 · shares: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, and subject to the achievement of applicable pre-established performance goals, 226 shares of restricted stock will vest on December 31, 2023, and the remaining 1,587 shares of restricted stock shall vest in seven substantially equal semi-annual installments beginning on May 12, 2024.

Read SEC document
December 15, 2023 Filed Dec 20, 2023 02:10 UTC
Vong JohnChief Accounting Officer
GrantCommon Stock 1,813 $0.00 $0.00
Disclosure

SEC source: 0001104659-23-127452 · tm2333076-9_4seq1.xml · nonDerivative · entry 2

Vong John · CIK 0001572846 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,527

F2 · shares: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, and subject to the achievement of applicable pre-established performance goals, 226 shares of restricted stock will vest on December 31, 2023, and the remaining 1,587 shares of restricted stock shall vest in seven substantially equal semi-annual installments beginning on May 12, 2024.

Read SEC document
December 15, 2023 Filed Dec 20, 2023 02:10 UTC
Vong JohnChief Accounting Officer
GrantCommon Stock 1,813 $0.00 $0.00
Disclosure

SEC source: 0001104659-23-127452 · tm2333076-9_4seq1.xml · nonDerivative · entry 1

Vong John · CIK 0001572846 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,714

F1 · shares: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, and subject to the achievement of applicable pre-established performance goals, 226 shares of restricted stock will vest on December 31, 2023, and the remaining 1,587 shares of restricted stock shall vest in seven substantially equal semi-annual installments beginning on May 12, 2024.

Read SEC document
December 06, 2023 Filed Dec 8, 2023 21:15 UTC Exercise / conversionStock Option (right to buy) · Derivative 7,500 $0.00 Strike: $18.11 $0.00
Disclosure

SEC source: 0001104659-23-124694 · tm2332434-2_4seq1.xml · derivative · entry 3

Schmidt David · CIK 0001594029 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,500 shares

Expires 2024-01-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: These stock options were granted on January 11, 2019 and were fully vested and exercisable.

Read SEC document
December 06, 2023 Filed Dec 8, 2023 21:15 UTC Disposition to issuerCommon Stock 7,500 $33.49 $251,175.00
Disclosure

SEC source: 0001104659-23-124694 · tm2332434-2_4seq1.xml · nonDerivative · entry 2

Schmidt David · CIK 0001594029 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · kind: These shares were repurchased by the issuer.

Read SEC document
December 06, 2023 Filed Dec 8, 2023 21:15 UTC Exercise / conversionCommon Stock 7,500 $18.11 $135,825.00
Disclosure

SEC source: 0001104659-23-124694 · tm2332434-2_4seq1.xml · nonDerivative · entry 1

Schmidt David · CIK 0001594029 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 06, 2023 Filed Dec 8, 2023 21:15 UTC Exercise / conversionStock Option (right to buy) · Derivative 7,500 $0.00 Strike: $18.11 $0.00
Disclosure

SEC source: 0001104659-23-124691 · tm2332434-1_4seq1.xml · derivative · entry 3

Kitayama Mitchell W · CIK 0001333154 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,500 shares

Expires 2024-01-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: These stock options were granted on January 11, 2019 and were fully vested and exercisable.

Read SEC document
December 06, 2023 Filed Dec 8, 2023 21:15 UTC Disposition to issuerCommon Stock 7,500 $33.49 $251,175.00
Disclosure

SEC source: 0001104659-23-124691 · tm2332434-1_4seq1.xml · nonDerivative · entry 2

Kitayama Mitchell W · CIK 0001333154 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · kind: These shares were repurchased by the issuer.

Read SEC document
December 06, 2023 Filed Dec 8, 2023 21:15 UTC Exercise / conversionCommon Stock 7,500 $18.11 $135,825.00
Disclosure

SEC source: 0001104659-23-124691 · tm2332434-1_4seq1.xml · nonDerivative · entry 1

Kitayama Mitchell W · CIK 0001333154 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 30, 2023 Filed Dec 5, 2023 02:10 UTC
Vong JohnChief Accounting Officer
Tax withholdingCommon Stock 65 $33.23 $2,159.95
Disclosure

SEC source: 0001104659-23-123379 · tm2332139-1_4seq1.xml · nonDerivative · entry 1

Vong John · CIK 0001572846 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,901

F1 · shares: This transaction represents the surrender of shares to offset against tax withholding obligations associated with certain shares of the restricted stock award that vested on November 30, 2023.

F2 · balance_after: Includes 4,159 shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 2,829 shares, of which 942 shares vest on each of July 11, 2024 and July 11, 2025 and 945 shares vest on July 11, 2026; (ii) 570 shares, which vest in three equal annual installments beginning on November 30, 2024; and (iii) 760 shares, which will vest upon achievement of certain pre-established performance goals.

Read SEC document
November 14, 2023 Filed Nov 16, 2023 21:31 UTC
Lam Thomas S.Director · Co-CEO and President
Sim Kenneth T.Director · Executive Chairman
Young Albert WaiChowChief Administrative Officer
Disposition to issuerCommon Stock 3,166,561 $31.58 $99,999,996.38
Disclosure

SEC source: 0001104659-23-119144 · tm2330683-1_4seq1.xml · nonDerivative · entry 1

ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp · CIK 0001725602 · 10% owner

Lam Thomas S. · CIK 0001664499 · Director · Co-CEO and President

Sim Kenneth T. · CIK 0001725499 · Director · Executive Chairman

Young Albert WaiChow · CIK 0001725420 · Chief Administrative Officer

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,132,698

F2 · kind: On November 6, 2023, the issuer entered into a stock repurchase agreement with APC, pursuant to which the issuer agreed to repurchase approximately $100 million of the issuer's common stock from APC. Pursuant to such agreement, on November 14, 2023, the issuer repurchased 3,166,561 shares of common stock from APC. The issuer's Board of Directors and the Audit Committee of the Board of Directors approved the repurchase.

F1 · ownership.direct: Allied Physicians of California, a Professional Medical Corporation ("APC") is a consolidated affiliate of the issuer of which Dr. Thomas Lam, the issuer's Co-Chief Executive Officer and President and a director, is the Chief Executive Officer and Chief Financial Officer and a director and stockholder; Dr. Kenneth Sim, the issuer's Executive Chairman, is Chairman and a director and stockholder; and Dr. Albert Young, the issuer's Chief Administrative Officer, is Senior Executive Vice President and a director and stockholder. Each of Dr. Lam, Dr. Sim and Dr. Young disclaims beneficial ownership of the securities held by APC except to the extent of his pecuniary interest therein. Each of Dr. Lam, Dr. Sim and Dr. Young holds, directly and/or indirectly, additional securities of the issuer.

Read SEC document
July 11, 2023 Filed Nov 16, 2023 21:30 UTC
Vong JohnChief Accounting Officer
Tax withholdingCommon Stock 325 $32.07 $10,422.75
Disclosure

SEC source: 0001104659-23-119141 · tm2330683-2_4seq1.xml · nonDerivative · entry 8

Vong John · CIK 0001572846 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,966

F6 · shares: This transaction represents the surrender of shares to offset against tax withholding obligations associated with certain shares of the restricted stock award that vested on July 11, 2023.

F7 · balance_after: Includes 4,349 shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 2,829 shares, of which 942 shares vest on each of July 11, 2024 and July 11, 2025 and 945 shares vest on July 11, 2026; (ii) 760 shares, which vest in four equal annual installments beginning on November 30, 2023; and (iii) 760 shares, which vest upon achievement of certain pre-established performance goals.

Read SEC document
July 01, 2023 Filed Nov 16, 2023 21:30 UTC
Vong JohnChief Accounting Officer
Disposition to issuerCommon Stock 1,520 $0.00 $0.00
Disclosure

SEC source: 0001104659-23-119141 · tm2330683-2_4seq1.xml · nonDerivative · entry 7

Vong John · CIK 0001572846 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,291

F3 · shares: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. The shares of restricted stock were scheduled to vest upon achievement of a pre-established performance goal on or before July 1, 2023. The applicable performance goal was not met, and the restricted shares were forfeited.

Read SEC document
July 01, 2023 Filed Nov 16, 2023 21:30 UTC
Vong JohnChief Accounting Officer
Disposition to issuerCommon Stock 1,520 $0.00 $0.00
Disclosure

SEC source: 0001104659-23-119141 · tm2330683-2_4seq1.xml · nonDerivative · entry 6

Vong John · CIK 0001572846 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,811

F2 · shares: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. The shares of restricted stock were scheduled to vest upon achievement of a pre-established performance goal on or before July 1, 2023. The applicable performance goal was not met, and the restricted shares were forfeited.

Read SEC document
May 16, 2023 Filed May 26, 2023 00:31 UTC
Sim BrandonCo-Chief Executive Officer
GrantCommon Stock 380,053 $0.00 $0.00
Disclosure

SEC source: 0001250853-23-000034 · primary_doc.xml · nonDerivative · entry 1

Sim Brandon · CIK 0001813532 · Co-Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 902,620

F1 · shares: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, 136,819 of the shares shall vest in eight equal (as nearly as possible) semi-annual installments, beginning on March 31, 2023. The remaining 243,234 shares shall vest upon achievement of certain pre-established performance goals.

Read SEC document
May 16, 2023 Filed May 26, 2023 00:25 UTC
Basho ChandanSee Remarks
GrantCommon Stock 130,732 $0.00 $0.00
Disclosure

SEC source: 0001250853-23-000033 · primary_doc.xml · nonDerivative · entry 1

Basho Chandan · CIK 0001929126 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 207,671

F1 · shares: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, the shares shall vest as follows: (i) 9,121 of the shares shall vest in two equal (as nearly as possible) annual installments beginning on May 17, 2024; (ii) 60,808 of the shares shall vest in six equal (as nearly as possible) semi-annual installments, beginning on October 12, 2023; and (iii) the remaining 60,803 shares shall vest upon achievement of certain pre-established performance goals.

Read SEC document
May 16, 2023 Filed Oct 17, 2023 20:16 UTC Amendment
Basho ChandanSee Remarks
GrantCommon Stock 60,803 $0.00 $0.00
Disclosure

SEC source: 0001104659-23-109616 · tm2326115-2_4aseq1.xml · nonDerivative · entry 4

Basho Chandan · CIK 0001929126 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 157,091

F4 · shares: Represents restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, the shares shall vest upon achievement of certain pre-established performance goals.

F5 · shares: These grants were previously reported in the aggregate in the original Form 4 filed on May 25, 2023.

F6 · balance_after: Includes 152,372 shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 21,640 shares, which vest in three equal annual installments on April 14, 2024, 2025, and 2026; (ii) 9,121 shares, which vest in two equal annual installments on May 16, 2024 and 2025; (iii) 60,808 shares, which vest in four equal annual installments on May 16, 2024, 2025, 2026 and 2027; and (iv) 60,803 shares, which vest upon achievement of certain pre-established performance goals.

Read SEC document
May 16, 2023 Filed Oct 17, 2023 20:16 UTC Amendment
Basho ChandanSee Remarks
GrantCommon Stock 60,808 $0.00 $0.00
Disclosure

SEC source: 0001104659-23-109616 · tm2326115-2_4aseq1.xml · nonDerivative · entry 3

Basho Chandan · CIK 0001929126 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 96,288

F3 · shares: Represents restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, the shares shall vest in four equal (as nearly as possible) annual installments, beginning on May 16, 2024.

F5 · shares: These grants were previously reported in the aggregate in the original Form 4 filed on May 25, 2023.

Read SEC document
May 16, 2023 Filed Oct 17, 2023 20:16 UTC Amendment
Basho ChandanSee Remarks
GrantCommon Stock 9,121 $0.00 $0.00
Disclosure

SEC source: 0001104659-23-109616 · tm2326115-2_4aseq1.xml · nonDerivative · entry 2

Basho Chandan · CIK 0001929126 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,480

F2 · shares: Represents restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, the shares shall vest in two equal (as nearly as possible) annual installments beginning on May 16, 2024.

F5 · shares: These grants were previously reported in the aggregate in the original Form 4 filed on May 25, 2023.

Read SEC document
May 16, 2023 Filed Oct 17, 2023 20:16 UTC Amendment
Basho ChandanSee Remarks
Disposition to issuerCommon Stock 48,086 $0.00 $0.00
Disclosure

SEC source: 0001104659-23-109616 · tm2326115-2_4aseq1.xml · nonDerivative · entry 1

Basho Chandan · CIK 0001929126 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,359

F1 · shares: Represents cancellation of previously-granted performance-based restricted stock award. The original Form 4 filed on May 25, 2023 inadvertently omitted this cancellation. Total holdings in column 5 have been adjusted accordingly, including for previously-reported tax withholdings.

Read SEC document
May 16, 2023 Filed Nov 16, 2023 21:30 UTC
Vong JohnChief Accounting Officer
GrantCommon Stock 760 $0.00 $0.00
Disclosure

SEC source: 0001104659-23-119141 · tm2330683-2_4seq1.xml · nonDerivative · entry 5

Vong John · CIK 0001572846 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,331

F5 · shares: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, the shares of restricted stock shall vest in four equal annual installments beginning on November 30, 2023 and upon achievement of a pre-established performance goal.

Read SEC document
May 16, 2023 Filed Nov 16, 2023 21:30 UTC
Vong JohnChief Accounting Officer
GrantCommon Stock 760 $0.00 $0.00
Disclosure

SEC source: 0001104659-23-119141 · tm2330683-2_4seq1.xml · nonDerivative · entry 4

Vong John · CIK 0001572846 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,571

F4 · shares: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, the shares of restricted stock shall vest in four equal annual installments beginning on November 30, 2023 and upon achievement of a pre-established performance goal on or before July 1, 2023, which performance goal was met.

Read SEC document
May 16, 2023 Filed Nov 16, 2023 21:30 UTC
Vong JohnChief Accounting Officer
GrantCommon Stock 1,520 $0.00 $0.00
Disclosure

SEC source: 0001104659-23-119141 · tm2330683-2_4seq1.xml · nonDerivative · entry 3

Vong John · CIK 0001572846 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,811

F3 · shares: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. The shares of restricted stock were scheduled to vest upon achievement of a pre-established performance goal on or before July 1, 2023. The applicable performance goal was not met, and the restricted shares were forfeited.

Read SEC document
May 16, 2023 Filed Nov 16, 2023 21:30 UTC
Vong JohnChief Accounting Officer
GrantCommon Stock 1,520 $0.00 $0.00
Disclosure

SEC source: 0001104659-23-119141 · tm2330683-2_4seq1.xml · nonDerivative · entry 2

Vong John · CIK 0001572846 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,291

F2 · shares: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. The shares of restricted stock were scheduled to vest upon achievement of a pre-established performance goal on or before July 1, 2023. The applicable performance goal was not met, and the restricted shares were forfeited.

Read SEC document
May 16, 2023 Filed Nov 16, 2023 21:30 UTC
Vong JohnChief Accounting Officer
Disposition to issuerCommon Stock 4,164 $0.00 $0.00
Disclosure

SEC source: 0001104659-23-119141 · tm2330683-2_4seq1.xml · nonDerivative · entry 1

Vong John · CIK 0001572846 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,771

F1 · shares: Represents cancellation of all performance-based restricted stock awards granted on December 12, 2022.

Read SEC document
April 14, 2023 Filed Oct 17, 2023 20:15 UTC
Basho ChandanSee Remarks
Tax withholdingCommon Stock 2,494 $39.06 $97,415.64
Disclosure

SEC source: 0001104659-23-109615 · tm2326115-1_4seq1.xml · nonDerivative · entry 1

Basho Chandan · CIK 0001929126 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 74,445

F1 · shares: This transaction represents the surrender of shares to offset against tax withholding obligations associated with certain shares of the restricted stock award which vested on April 14, 2023.

F2 · balance_after: Includes 69,726 shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 21,640 shares, which vest in three equal annual installments on April 14, 2024, 2025, and 2026; and (ii) 48,086 shares, which vest upon achievement of certain pre-established performance goals.

Read SEC document
March 14, 2023 Filed Mar 15, 2023 20:32 UTC
Dong LindaDirector
Disposition to issuerCommon Stock 270,081 $35.32 $9,539,260.92
Disclosure

SEC source: 0001628280-23-008109 · wf-form4_167891236085499.xml · nonDerivative · entry 1

Marsh Linda · CIK 0001765204 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Alliance Apex, LLC

Disclosed balance after: 0

F1 · ownership.nature: These shares are owned directly by Alliance Apex, LLC, of which Reporting Person is a member and the sole manager. Reporting Person disclaims beneficial ownership of these shares except to the extent of her pecuniary interest therein, and the filing of this report is not an admission that Reporting Person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose.

Read SEC document
March 09, 2023 Filed Mar 13, 2023 16:40 UTC
Dong LindaDirector
Exercise / conversionStock Option (right to buy) · Derivative 62,500 $0.00 Strike: $10.00 $0.00
Disclosure

SEC source: 0001250853-23-000009 · primary_doc.xml · derivative · entry 5

Marsh Linda · CIK 0001765204 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 62,500 shares

Expires 2023-04-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The stock options were granted on March 4, 2020 and vested and became exercisable on the date of the grant.

Read SEC document
March 09, 2023 Filed Mar 13, 2023 16:40 UTC
Dong LindaDirector
Exercise / conversionCommon Stock 62,500 $10.00 $625,000.00
Disclosure

SEC source: 0001250853-23-000009 · primary_doc.xml · nonDerivative · entry 1

Marsh Linda · CIK 0001765204 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 12, 2022 Filed Dec 13, 2022 23:11 UTC
Vong JohnSVP-Chief Accounting Officer
GrantCommon Stock 694 $0.00 $0.00
Disclosure

SEC source: 0001628280-22-031872 · wf-form4_167097305185321.xml · nonDerivative · entry 4

Vong John · CIK 0001572846 · SVP-Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,935

F4 · shares: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, 519 shares shall vest in three equal annual installments beginning on November 30, 2023. The remaining 175 shall vest on November 30, 2026. Such vesting is subject to achievement of a pre-established performance goal on or before November 30, 2026.

Read SEC document
December 12, 2022 Filed Dec 13, 2022 23:11 UTC
Vong JohnSVP-Chief Accounting Officer
GrantCommon Stock 694 $0.00 $0.00
Disclosure

SEC source: 0001628280-22-031872 · wf-form4_167097305185321.xml · nonDerivative · entry 3

Vong John · CIK 0001572846 · SVP-Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,241

F3 · shares: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, 519 shares shall vest in three equal annual installments beginning on November 30, 2023. The remaining 175 shall vest on November 30, 2026. Such vesting is subject to achievement of a pre-established performance goal on or before April 1, 2023.

Read SEC document
December 12, 2022 Filed Dec 13, 2022 23:11 UTC
Vong JohnSVP-Chief Accounting Officer
GrantCommon Stock 1,388 $0.00 $0.00
Disclosure

SEC source: 0001628280-22-031872 · wf-form4_167097305185321.xml · nonDerivative · entry 2

Vong John · CIK 0001572846 · SVP-Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,547

F2 · shares: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, the shares of restricted stock shall vest in four equal annual installments beginning on November 30, 2023 and upon achievement of a pre-established performance goal on or before July 1, 2023.

Read SEC document
December 12, 2022 Filed Dec 13, 2022 23:11 UTC
Vong JohnSVP-Chief Accounting Officer
GrantCommon Stock 1,388 $0.00 $0.00
Disclosure

SEC source: 0001628280-22-031872 · wf-form4_167097305185321.xml · nonDerivative · entry 1

Vong John · CIK 0001572846 · SVP-Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,159

F1 · shares: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, the shares of restricted stock shall vest in four equal annual installments beginning on November 30, 2023 and upon achievement of a pre-established performance goal on or before April 1, 2023.

Read SEC document
December 08, 2022 Filed Dec 12, 2022 23:50 UTC
Sim Kenneth T.Director · Executive Chairman
Exercise / conversionWarrants to purchase Common Stock · Derivative 48,587.12 Not disclosed Strike: $11.00 Not disclosed
Disclosure

SEC source: 0001250853-22-000121 · primary_doc.xml · derivative · entry 8

Sim Kenneth T. · CIK 0001725499 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 48,587.12 shares

Expires 2022-12-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · price: On December 8, 2017, a reverse merger transaction between the Issuer and Network Medical Management, Inc. ("NMM") was consummated such that NMM became a wholly-owned subsidiary of the Issuer (the "Merger). Immediately prior to the closing of the Merger, the Reporting Person was a shareholder of NMM. Pursuant to the Merger, the shares of NMM common stock previously held by Reporting Person were converted into (i) 1,563,804 shares of common stock of the Issuer, (ii) a warrant to purchase 48,587.12 shares of common stock of the Issuer at an exercise price of $11.00 per share, (iii) a warrant to purchase 51,445.18 shares of common stock of the Issuer at an exercise price of $10.00 per share, (iv) cash in lieu of fractional shares, and (v) the Reporting Person's pro rata portion, if any, of the holdback shares of common stock of the Issuer (such pro rata portion of the holdback shares would, without offset, initially be equal to 173,756.04 shares of common stock of the Issuer).

Read SEC document
December 08, 2022 Filed Dec 12, 2022 23:50 UTC
Sim Kenneth T.Director · Executive Chairman
Exercise / conversionWarrants to purchase Common Stock · Derivative 51,445.18 Not disclosed Strike: $10.00 Not disclosed
Disclosure

SEC source: 0001250853-22-000121 · primary_doc.xml · derivative · entry 7

Sim Kenneth T. · CIK 0001725499 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 51,445.18 shares

Expires 2022-12-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · price: On December 8, 2017, a reverse merger transaction between the Issuer and Network Medical Management, Inc. ("NMM") was consummated such that NMM became a wholly-owned subsidiary of the Issuer (the "Merger). Immediately prior to the closing of the Merger, the Reporting Person was a shareholder of NMM. Pursuant to the Merger, the shares of NMM common stock previously held by Reporting Person were converted into (i) 1,563,804 shares of common stock of the Issuer, (ii) a warrant to purchase 48,587.12 shares of common stock of the Issuer at an exercise price of $11.00 per share, (iii) a warrant to purchase 51,445.18 shares of common stock of the Issuer at an exercise price of $10.00 per share, (iv) cash in lieu of fractional shares, and (v) the Reporting Person's pro rata portion, if any, of the holdback shares of common stock of the Issuer (such pro rata portion of the holdback shares would, without offset, initially be equal to 173,756.04 shares of common stock of the Issuer).

Read SEC document
December 08, 2022 Filed Dec 12, 2022 23:50 UTC
Sim Kenneth T.Director · Executive Chairman
Exercise / conversionCommon Stock 48,587 $11.00 $534,457.00
Disclosure

SEC source: 0001250853-22-000121 · primary_doc.xml · nonDerivative · entry 2

Sim Kenneth T. · CIK 0001725499 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 291,859

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.